Beta Bionics, Inc. Common Stock (NASDAQ: BBNX) last traded at $19.05, down 2.21% on the session. The quote above updates while this page is open; the figures below are drawn from Beta Bionics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Beta Bionics, Inc. Common Stock trades on NASDAQ under the ticker BBNX. Its market capitalisation is $857.05 million.
Valuation measures for Beta Bionics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $857.05M |
|---|---|
| Enterprise value | $848.76M |
| Price / sales | 7.20 |
| Price / book | 3.34 |
| Beta | 1.32 |
Trailing-twelve-month figures tagged in Beta Bionics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $119.01M |
|---|---|
| Net income (TTM) | -$72.97M |
| EPS (TTM) | -$1.51 |
| Gross margin | 58.31% |
| Operating margin | -69.75% |
| Return on equity | -28.46% |
| Cash | $44.32M |
Range and volume for BBNX over the past 52 weeks.
| 52-week high | $32.71 |
|---|---|
| 52-week low | $8.80 |
| Volume | 494.9K |
| Average volume | 1.16M |
| Previous close | $19.48 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.